Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0GX2A
|
||||
Former ID |
DNC011362
|
||||
Drug Name |
NSC-87509
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C18H12O10
|
||||
Canonical SMILES |
CC1=CC(=C(C2=C1C(=O)OC3=C(O2)C4=C(C(=C3CO)O)C(=O)OC4O)C<br />=O)O
|
||||
InChI |
1S/C18H12O10/c1-5-2-8(21)6(3-19)13-9(5)16(23)27-14-7(4-20)12(22)10-11(15(14)26-13)18(25)28-17(10)24/h2-3,18,20-22,25H,4H2,1H3
|
||||
InChIKey |
QQTKVXCQLZIJPP-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Voltage-dependent N-type calcium channel | Target Info | Inhibitor | [1] | |
KEGG Pathway | MAPK signaling pathway | ||||
Calcium signaling pathway | |||||
Synaptic vesicle cycle | |||||
Retrograde endocannabinoid signaling | |||||
Cholinergic synapse | |||||
Serotonergic synapse | |||||
GABAergic synapse | |||||
Dopaminergic synapse | |||||
Taste transduction | |||||
Type II diabetes mellitus | |||||
Morphine addiction | |||||
Nicotine addiction | |||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
Ionotropic glutamate receptor pathway | |||||
Metabotropic glutamate receptor group III pathway | |||||
Metabotropic glutamate receptor group II pathway | |||||
Thyrotropin-releasing hormone receptor signaling pathway | |||||
Endogenous cannabinoid signaling | |||||
GABA-B receptor II signaling | |||||
Reactome | Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels | ||||
WikiPathways | Calcium Regulation in the Cardiac Cell | ||||
Synaptic Vesicle Pathway | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. Epub 2010 Oct 21.In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.